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Abstract:We have used a glucose oxidase-based sensor
implanted in the striatum of freely moving rats to deter-
mine the concentration of extracellular glucose in two
distinct ways. With a modification of the zero net flux
method, in which different concentrations of glucose are
infused through a dialysis probe glued to the biosensor,
we calculated the concentration at which there was no
change in glucose current by regression analysis; this
gave a concentration of 0.351 ±0.016 mM. Calculating
the concentration from the basal current and the in vitro
calibration of the biosensor was not significantly different
from this. The basal extracellular glucose concentration
determined by either method remained constant over a
period of several days. Infusion of 50 1aM veratridine
through the adjacent dialysis probe caused a steep de-
crease in glucose current as soon as the drug reached
the brain in contrast to the delayed fall (7.5 mm) seen
with microdialysis in previous experiments from this labo-
ratory. These results demonstrate that this biosensor pro-
vides a direct, real-timemeasure of the extracellular con-
centration of glucose. Key Words: Glucose biosensor—
Brain glucose concentration—Veratridine— Rat striatum.
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The concentration of brain extracellular glucose has
been calculated from whole-brain glucose and the vol-
ume of the extracellular compartment (Lund-Ander-
son, 1979); such measurements have estimated the
extracellular glucose concentration as 2.0 mM. More
recently, brain extracellular glucose has been moni-
tored in vivo using microdialysis. The true extracellu-
lar concentration of glucose cannot be derived from
dialysate concentration using the in vitro probe recov-
ery (Morrison et al., 1991). Application of the zero
net flux (ZNF) method (Lönnroth et al., 1987) has
given values of 0.47 mM (Fellows et al., 1992) and
0.35 mM(Fray et al., 1997) in the striatum of unanaes-
thetised rats and 3.3 mM in the cortex of anaesthetised
rats (Ronne-Engstrom et al., 1995). Another approach
is to use an amperometric biosensor. Measurement of
glucose with an implanted glucose oxidase (GOx)
electrode has found a concentration of 2.5 mM in the
hypothalamus of the sodium pentobarbitone-anaesthe-
tised rat (Silver and Ereciñska, 1994) and 1.5 mM
in the cortex of the chloral hydrate-anaesthetised rat
(Netchiporouk et al., 1996).
We have developed a glucose biosensor based on
the immobilisation of GOx on Pt electrodes with the
polymer poly(o-phenylenediamine) (PPD) (Lowry
and O’Neill, 1994) and have used it to monitor contin-
uously rapid changes in glucose in response to physio-
logical stimulation (Lowry and Fillenz, 1997). An im-
portant stage in the development of this biosensor was
the in vitro and in vivo characterisation of the sensor,
which demonstrated that it has a fast response time, is
linear over the relevant concentration range, is free of
protein and lipid fouling, and has minimal interference
from endogenous species (Lowry and O’Neill, 1994;
Lowry et a!., 1994b; Lowry and Fillenz, 1997).
There is some controversy concerning the immedi-
ate source of glucose in the extracellular compartment
(Forsyth et al., 1996). An accurate determination of
the true extracellular concentration is critical for the
resolution of this controversy. The present study was
designed to determine the true extracellular concentra-
tion of glucose using the implanted biosensor and to
compare the two approaches to the measurement of
extracellular glucose concentration (amperometry and
microdialysis) in the same animal. We used a recent
modification of the ZNF method of Lönnroth et al.
(1987), in which an implanted electrode is combined
with a dialysis probe (Miele and Fillenz, 1996) to
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determine the extracellular concentration of glucose in
the striatum of freely moving rats. We then compared
this value with that derived from using the in vitro
calibration of the biosensor.
MATERIALS AND METHODS
Reagents and solutions
The enzyme GOx from Aspergillus niger (EC 1.1.3.4,
grade I) was obtained from Genzyme (West Malling, Kent,
U.K.). o-Phenylenediamine (free base) and veratridine (free
base) were from Sigma Chemical Co. (Dorset, U.K.). D ( + ) -
Glucose (AnalaR grade) was obtained from BDH Labora-
tory Supplies (Poole, U.K.). NaCl, KC1, NaH2PO4, NaOH,
MgCl2 (all BDH, AnalaR grade), and CaC12 (Sigma) were
used as supplied.
Stock 1 M solutions of glucose for in vitro calibrations
were prepared, left for 24 h at room temperature to allow
equilibration of the anomers, and then stored at 4°C.Stock
solutions of 100 mM ascorbic acid for in vitro calibrations
were prepared just before use because of their gradual de-
composition. All experiments in vitro were carried out in
phosphate-buffered saline solution (pH 7.4): 150 mM NaCl,
40 mM NaH2PO4. Glucose solutions used in in vivo experi-
ments (microdialysis) were prepared in artificial cerebrospi-
nal fluid (aCSF): 147 mM NaCl, 4mM KC1, 1.2 mM CaCl2,
and 1 mM MgCl2 (de Boer et al., 1990). Veratridine solu-
tions were prepared in aCSF and sonicated with heating to
ensure complete dissolution. All solutions were prepared us-
ing deoxygenated, deionised water.
Instrumentation and software
A low-noise potentiostat (Biostat II; Electrochemical and
Medical Systems, Newbury, U.K.) was used in all experi-
ments. Data acquisition was performed using a Macintosh
lix computer and a National Instruments (National Instru-
ments Corp., Austin, TX, U.S.A.) NB-MIO-16X multifunc-
tion data acquisition board. Further noise reduction was
achievedby averaging 75 determinations to give 1 data point
every 2 s. All experiments were performed using in-house
developed software: LabVIEW (National Instruments
Corp.). All analyses were performed using both in-house
developed software and the commercial packages Igor Pro
2.0 (WaveMetrics, OR, U.S.A.) and Prism (GraphPad Soft-
ware, CA, U.S.A.).
Surgery
Male Sprague—Dawley rats weighing 200—300 g were
anaesthetised as described previously (Lowry and Fillenz,
1997). A mixture of 0.25 mg/kg fentanyl, 0.8 mg/kg flua-
nisone, and 0.4 mg/kg midazolam was injected intraperito-
neally at a volume of 3.3 mi/kg. Surgery typically lasted
40 mm, and anaesthesia was reversed by an intraperitoneal
injection of naloxone (0.1 mg/kg; Sigma). Subsequently,
animals were given Vetergesic (Reckitt and Colman Phar-
maceuticals, Hull, U.K.) and narcotic buprenorphine (0.1
mg/kg s.c.) for pain relief. Occasionally, when surgery took
longer, the animal was given a further intramuscular injec-
tion of 0.1 ml of Hypnorm every 10 mm beyond 30 mm.
Once surgical anaesthesia was established, animals were
placed in a stereotaxic frame. Body temperature was main-
tained at 37°Cthroughout the surgery with an isothermal
heating pad (Braintree Scientific, Braintree, MA, U.S.A.).
The Pt/PPD/GOx electrode, glued to amicrodialysis probe,
was implanted in the right striatum [coordinates with the
skull levelled between bregma and lambda were A/P +1.0
from bregma, M/L +2.5, and DIV —8.5 from dura (Paxinos
and Watson, 1986)1. The reference electrode (8T silver
wire, 200-~smbare diameter; Advent Research Materials)
was placed in the cortex, the auxiliary electrode (8T silver
wire) was placed between the skull and dura, and an earth
wire (8T silver wire) was attached to one of the support
screws. The electrodes and probe were attached to the socket
fixed to the skull with dental screws and dental acrylate
(Associated DentalProducts, Swindon, U.K.). Animals were
allowed 24 h to recover after surgery.
Animals were assessed for discomfort using the guidelines
of Morton and Griffiths (1985). All animals used in this
study had a score of 2, as defined by Morton and Griffiths.
In cases where the score was >2, the experiment was termi-
nated. All procedures were specifically licensed under the
Animals (Scientific Procedures) Act, 1986.
Glucose biosensor
The Pt/PPDIGOx electrodes were made from ST (125-
~smbare diameter, l60-~smcoated diameter) Teflon-coated
platinum/iridium (Pt/Ir 90/10%) wire (Advent Research
Materials). Approximately 4 mm of theTeflon was cut from
one end to produce a 4-mm active length of bare wire. GOx
was immobilised using PPD by potentiostatic electropoly-
merisation of theo-phenylenediamine monomer (300 mmol/
L) following a modified form of a previously reportedproce-
dure (Lowry and O’Neill, 1994; Lowry and Fillenz, 1997).
In all experiments constant potential amperometry at
+700 mV was used to detect glucose by oxidising H202
formed from the following enzyme reaction:
D-glucose + GOx/FAD —° D-gluconolactone + GOx/FADH2
GOx/FADH2 + 02 -~ GOx/FAD + H2O2
H202 -° 02 + 2W + 2e
Prior to implantation all Pt/PPD/GOx electrodes were
preconditioned in vitro by continuous recording in 5 mM
glucose over a 10-h period, which was found to improve the
stability. Electrodes were then calibrated in vitro for both
glucose (0—100 mmollL) and ascorbic acid (0—1 mmolIL)
to ensure selectivity and linearity of response of the sensor
to glucose (Lowry and O’Neill, 1994). A characterised Pt/
PPD/GOx electrode was glued with epoxyto a microdialysis
probe ‘-~1 h prior to implantation so that the 4-mm active
lengths of both probe and electrode were directly aligned.
Care was taken to ensure that the distance between the probe
and electrode was within 1 mm.
Microdialysis probe construction
Concentric microdialysis probes were constructed as de-
scribed previously (Demestre et al., 1997). The length of
the probe was 4 mm, and the external diameter of the sam-
pling region of the probe was 300 ~sm.
Experimental procedures
The rats were housed in large plastic bowls (diameter 20
in), in a windowless room (12-h light, 12-h dark cycle,
lights coming on at 8 a.m.), with free access to food and
water. Experiments were carried out with the animal in its
home bowl. Implanted electrodes were connected to the po-
tentiostat through a six-pin Teflon socket and a flexible
screened six-core cable that was mounted through a swivel
above the rat’s head (Semat Technical, Herts, U.K.) at least
60 mm prior to the start of each experiment. This arrange-
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ment allowed free movement of the animal. Once the back-
ground current for the Pt/PPD!GOx electrode had stabilised
(typically 30—45 mm), experiments began.
For microdialysis experiments involving the ZNF method
and the combined sensor/probe, the experimental procedure
was similar to that used recently for thequantitative determi-
nation of brain extracellular ascorbic acid (Miele andFillenz,
1996). In brief, glucose solutions ranging from 100 to 1,000
~.eMwere perfused in random order throughthedialysis probe
at a flow rate of 2 ~.tl/min.The current from the adjacent Pt!
PPD!GOx electrode was recorded continuously during the
perfusion. Changes in current were allowed to reach a steady
state (typically between 10 and 20 mm) before perfusion
was stopped and the current allowed to return to baseline
values. These changes were then plotted against the glucose
inflow concentration; the point at which no change in current
occurred, calculated by linear regression, was the point
of ZNF.
Presentation of results
Data are presented as means ±SEM with n equalling the
number of rats. Statistics (StatView; Abacus Concepts, CA,
U.S.A.) were performed using the Student t test for paired
observations (two tailed), with p < 0.05 considered to be
significant.
RESULTS
ZNF experiments
Combined Pt/PPD/GOx sensors and microdialysis
probes were implanted in the right striatum of freely
moving rats and the modified Lonnroth ZNF method
used to determine the true extracellular concentration
of glucose in situ. Perfusion of glucose concentrations
lower or higher than that in the extracellular fluid
(ECF) resulted in a net loss or gain from the tissue
into the dialysis probe and was characterised by a de-
crease or increase in the Pt/PPD/GOx current. A typi-
cal example of the effects of perfusing 1,000 1aM glu-
cose and aCSF is shown in Fig. 1. Random perfusion
of concentrations above and below the point of ZNF
resulted in quite rapid changes in the glucose current,
which reached a steady state usually within 10—15
mm. However, once perfusion was stopped, the rgturn
to baseline or control values was longer for the higher
concentrations: 26 ±3 mm for 1,000 ~uMglucose (n
= 4, six determinations) and 6 ± 1 mm for aCSF (n
= 4, six determinations). With certain concentrations
there was little or no change in the glucose current,
indicating that these concentrations were close or equal
to the ECF concentration. As the animals were freely
moving, there were often periods during the perfusion
of glucose when the animals were quite active (e.g.,
feeding) and the glucose current required longer peri-
ods of time to reach steady-state conditions. Linear
regression analysis of a plot of the observed change
in current (I) versus perfused concentration yielded a
straight line (r
2 = 0.98 ±0.01) a d a mean ZNF point
of 0.351 ±0.Ol6mM(n = 4,11 determinations) (Fig.
2A), which represents the extracellular concentration
of glucose. In ZNF experiments carried out on 2 con-
FIG. 1. The effect on the glucose current at the biosensor,
shown as a percentage of basal current in the absence of perfu-
sion, of the infusion of 1 mM glucose (A) and the infusion of
aCSF (B) through the adjacent dialysis probe.
secutive days (1 and 2) in four animals, the calculated
extracellular concentrations were 0.373 ± 0.012 mM
for day 1 and 0.358 ±0.0 19 mM for day 2, adifference
that was not statistically significant (p > 0.57). This
is in contrast to our early microdialysis data in which
dialysate glucose levels showed a progressive decrease
(Fellows et al., 1992).
In vitro calibrations
In the alternative approach, we calculated basal glu-
cose levels from the baseline currents recorded in vivo
and invitro calibrationdata, and compared these values
with those obtained using the ZNF method. The in
vitro sensitivity of the Pt/PPD/GOx electrodes for glu-
cose was 61 ±25 nA/mM (n = 4). The difference
in glucose concentration calculated from the in vitro
calibration of the four biosensors and the value calcu-
lated from ZNF experiments carried out 24 h after
implantation was 48 ±86 ~sM, a difference not differ-
ent from 0 (n = 4, four determinations, p = 0.61, one-
tailed t test). When the comparison was made between
basal concentrations determined by these two methods
on days 1 and 2 after implantation, the difference was
19 ±49
1iM (n = 4, eight determinations, p = 0.7).
Similarly, there was no significant difference (p >
0.38) in the extracellular concentration calculated from
in vitro calibrations for day 1 (0.422 ±0.081 mM; n
= 4) and day 2 (0.398 ±0.069 mM; n = 4).
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during perfusion with aCSF, and 0.156 ± 0.025 mM
during perfusion with veratridine (Fig. 1B). This rep-
resents a reduction of 15 ±4% due to perfusion alone
and a further reduction of 46 ± 6% due to the action
of veratridine.
We next examined the effect of veratridine on the
extracellular glucose concentration using the ZNF
technique. In the absence of drug, the extracellular
concentration calculated by regression analysis was
0.380 ±0.010 mM. This was followed immediately
by a ZNF experiment in the presence of 50 ,uM veratri-
dine. Regression analysis (see Fig. 2B) gave a concen-
tration of 0.181 ±0.030 mM for the extracellular con-
centration of glucose in the presence of veratridine,
which represents a reduction of 52 ±9% (n = 4).
FIG. 2. Regression curves constructed from ZNF experiments
during infusion of normal perfusion medium (A) and during perfu-
sion with medium containing 50 ~sMveratridine (B). The curve
in A is a mean of 11 determinations; the curve in B is from a
single representative experiment.
Effect of veratridine
To see how accurately the biosensor can follow
changes in the extracellular concentration of glucose,
we carried out experiments using veratridine, which,
by opening voltage-gated sodium channels, stimulates
the Na + ,K + -ATPase and so increases energy require-
ments and glucose utilisation (Whitesell et al., 1995).
The basal extracellular current in the absence of perfu-
sion was 24 ±3 nA. Perfusion with aCSF reduced the
basal value to 20 ±3 nA. We next added veratridine
to the perfusion medium to a final concentration of 50
tiM. This caused a steep decrease in the glucose cur-
rent, which reached a new steady value at 10 ±3 nA
(n = 2, four determinations). After allowing for the
dead volume, the delay between veratridine reaching
the brain and the onset of the decrease of the glucose
current was <1 mm (Fig. 3). With use of in vitro
calibration of the biosensor, the concentrations of glu-
cose calculated from the currents were 0.285 ± 0.024
mM in the absence of perfusion, 0.240 ± 0.0 10 mM
Calculation of fluxes
A valuable method for the comparison of abiosensor
and microdialysis is to calculate the flux of glucose
removed using the equation J = i!nFA, where J is
the flux, i is the baseline current, n is the number of
electrons per molecule of H2O2 oxidised, F is the Fara-
day constant, and A is the area of the biosensor. Taking
15 nA as the value for the baseline current, 2 for
the value of n, 9.65 X iO~C/mol for the Faraday con-
stant, and 1.57 X 10_2 cm
2 for the area of the biose -
or yields a value of 5 p ol H
202 (glucose) oxidised/
s/cm
2.
For the microdialysis probe, the equation is J = fi
cA, where J is the flux, f is the flow rate, c is the
concentration in the dialysate, and A is the area of the
probe. Taking 2 ~il/min as the flow rate, 200 ,uM as
the concentration in the dialysate, and 0.3 X 4 mm2
as the area of the probe (Fray et al., 1996) gives a
value of 186 pmol/s/cm2.
FIG. 3. The effect on glucose current of the infusion of 50
1sM
veratridine through the adjacent dialysis probe.
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DISCUSSION
By testing the Pt/PPD/GOx biosensor in vivo, we
have established that it provides a true measure of
glucose concentration that is independent of changes
in oxygen concentration and free of interference by
ascorbate, the principal electroactive interferent pres-
ent in the ECF. These sensors also exhibit no signifi-
cant loss of sensitivity for several days following im-
plantation (Lowry et al., 1997).
The present study was undertaken to determine the
relation between the current recorded at the biosensor
and the true extracellular concentration of glucose. We
have shown previously, using microdialysis, that the
calculation of the concentration of glucose in the extra-
cellular compartment from the concentration in the di-
alysate requires a knowledge of the in vivo recovery,
which cannot be derived from in vitro recovery of the
probe (Fray et al., 1997). The ZNF method of Lönn-
roth et al. (1987) provides a value for both the extracel-
lular concentration and the in vivo recovery.
In the present study, we have used a modification
of the ZNF method, where instead of plotting infused
concentration against (in—out) concentration, changes
in the current at the implanted biosensor are used. The
point of zero current change, arrived at by regression
analysis, represents the point at which the infused con-
centration of glucose is the same as that throughout
the ECF. This value was 0.35 1 ±0.016 mM, which
is the same as the value of 0.350 ±0.020 mM derived
from use of the ZNF method with microdialysis (Fray
et al., 1997). It is clear (Fig. 1A) that infusion of
glucose concentrations above this value increases the
current and hence the local glucose concentration. We
have discussed the possible causes and implications of
this level of ECF glucose elsewhere (Forsyth et a!.,
1996; Fray et al., 1996).
We also calculated the basal extracellular glucose
concentration from the basal current and the preim-
plantation in vitro calibration of the biosensor. There
was no significant difference between this value aiid
that determined by the ZNF method in individual rats
and no difference between basal glucose determined by
either of these methods 24 and 48 h after implantation.
This finding has several implications. The first is
that there is little or no change in the sensitivity of the
biosensor following implantation, supporting previous
results (Lowry et al., 1994a). The second is that the
close agreement indicates that in vivo the biosensor
current represents only glucose. The third is that in
contrast to microdialysis, measurements with the im-
planted biosensor provide a direct, real-time measure
of the extracellular concentration of glucose.
In microdialysis the delivery of glucose to the dialy-
sate is by diffusion along a concentration gradient.
In addition to the dialysis membrane, the narrow and
tortuous clefts of the extracellular compartment offer
barriers to free diffusion and hence restrict the flux to
the probe. Processes of supply and utilisation increase
FIG. 4. A comparison ofthe time course of the effect of veratri-
dine on the glucose current at the biosensor (from Fig. 3, dotted
line) with the results from microdialysis experiments showing the
difference between changes in dialysate (filled circles) and the
calculated extracellular glucose concentration (open squares,
from Fray et al., 1997).
the concentration gradient and hence the flux from the
brain (Boutelle and Fillenz, 1996).
The removal of glucose by microdialysis varies with
flow rate and even at 2 ~tl/min is 41 times greater
than the removal by the enzyme-based biosensor. An
example of the effect of microdialysis is illustrated in
Fig. lB. The much smaller removal flux of the biosen-
sor is much more easily met by the tissue processes
surrounding the probe. Consequently, the local extra-
cellularconcentration is not perturbed by the electrode,
which records the true extracellular concentration.
We have shown that with microdialysis the in vivo
recovery increases with an increase in the rate of uti-
lisation. With the local administration of veratridine,
the steep decrease in extracellular concentration to-
gether with an increase in in vivo recovery meant that
therewas a delay of 7.5 mm in the decrease in dialysate
concentration (Fray et al., 1997). No such delay was
seen in the present experiments when glucose was
measured with the implanted biosensor (Fig. 4).
These findings all suggest that the biosensor pro-
vides a direct measure of the extracellular concentra-
tion of glucose, which can be calculated from the in
vitro calibration.
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